Response assessment in diffuse intrinsic pontine glioma: Recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group Guidelines


Authors: Cooney, T. M.; Cohen, K. J.; Guimaraes, C. V.; Dhall, G.; Leach, J.; Massimino, M.; Erbetta, A.; Chiapparini, L.; Malbari, F.; Kramer, K.; Pollack, I. F.; Baxter, P.; Laughlin, S.; Patay, Z.; Young Poussaint, T.; Warren, K. E.
Title: Response assessment in diffuse intrinsic pontine glioma: Recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group
Abstract: Optimising the conduct of clinical trials for diffuse intrinsic pontine glioma involves use of consistent, objective disease assessments and standardised response criteria. The Response Assessment in Pediatric Neuro-Oncology working group, consisting of an international panel of paediatric and adult neuro-oncologists, clinicians, radiologists, radiation oncologists, and neurosurgeons, was established to address issues and unique challenges in assessing response in children with CNS tumours. A working group was formed specifically to address response assessment in children and young adults with diffuse intrinsic pontine glioma and to develop a consensus on recommendations for response assessment. Response should be assessed using MRI of brain and spine, neurological examination, and anti-inflammatory or antiangiogenic drugs. Clinical imaging standards are defined. As with previous consensus recommendations, these recommendations will need to be validated in prospective clinical trials. © 2020 Elsevier Ltd
Keywords: treatment response; review; bevacizumab; nuclear magnetic resonance imaging; consensus; steroid; childhood cancer; tumor classification; disease exacerbation; drug use; neurology; neurologic examination; pontine glioma; human; priority journal
Journal Title: Lancet Oncology
Volume: 21
Issue: 6
ISSN: 1470-2045
Publisher: Elsevier Science, Inc.  
Date Published: 2020-06-01
Start Page: e330
End Page: e336
Language: English
DOI: 10.1016/s1470-2045(20)30166-2
PUBMED: 32502459
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 1 July 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kim Kramer
    238 Kramer